...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Private placement??
2
Jul 11, 2018 12:03AM
1
Jul 13, 2018 05:21AM
4
Jul 13, 2018 01:19PM

,,yes,,I had forgotten about the peer review,,,,it would certainly not hurt if positive!!,,,,the BoM trial, if successful, will add a significant amount of credence to the science at large!jmo

Share
New Message
Please login to post a reply